| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.635 | 0.005 | 0.635 | GABA C receptor rho-3 antagonist | 0.484 0.03 CID_80579 | ||
| 0.606 | 0.004 | 0.606 | Peroxidase inhibitor | 0.435 0.016 CID_80579 | ||
| 0.549 | 0.016 | 0.58 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.58 0.01 CID_80579 | CID_80579 | |
| 0.539 | 0.027 | 0.539 | Aldehyde oxidase inhibitor | 0.217 0.096 CID_80579 | ||
| 0.501 | 0.027 | 0.501 | 5 Hydroxytryptamine release stimulant | 0.219 0.107 CID_80579 | ||
| 0.469 | 0.005 | 0.469 | 5 Hydroxytryptamine uptake stimulant | 0.387 0.017 CID_80579 | ||
| 0.471 | 0.04 | 0.471 | Calcium channel L-type activator | 0.406 0.077 CID_80579 | ||
| 0.462 | 0.037 | 0.466 | Angiogenesis inhibitor | 0.466 0.036 CID_80579 | CID_80579 | |
| 0.413 | 0.007 | 0.413 | Interleukin 6 antagonist | 0.152 0.085 CID_80579 | ||
| 0.415 | 0.009 | 0.415 | Phospholipase C inhibitor | 0.225 0.031 CID_80579 | ||
| 0.452 | 0.05 | 0.533 | 5 Hydroxytryptamine release inhibitor | 0.533 0.023 CID_80579 | CID_80579 | |
| 0.417 | 0.019 | 0.417 | Calcium channel activator | 0.321 0.072 CID_80579 | ||
| 0.408 | 0.015 | 0.408 | Anesthetic general | 0.282 0.038 CID_80579 | ||
| 0.4 | 0.008 | 0.4 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.353 0.012 CID_80579 | ||
| 0.411 | 0.024 | 0.423 | Interleukin 2 agonist | 0.423 0.021 CID_80579 | CID_80579 | |
| 0.381 | 0.01 | 0.381 | Lipocortins synthesis antagonist | |||
| 0.389 | 0.029 | 0.389 | Superoxide dismutase inhibitor | 0.254 0.072 CID_80579 | ||
| 0.355 | 0.007 | 0.355 | GABA C receptor agonist | 0.136 0.04 CID_80579 | ||
| 0.414 | 0.068 | 0.477 | Histamine release inhibitor | 0.477 0.037 CID_80579 | CID_80579 | |
| 0.351 | 0.009 | 0.351 | Neurotrophic factor enhancer | 0.261 0.032 CID_80579 | ||
| 0.382 | 0.041 | 0.382 | Aryl hydrocarbon receptor agonist | 0.364 0.045 CID_80579 | ||
| 0.351 | 0.016 | 0.351 | Tyrosine 3 hydroxylase inhibitor | 0.297 0.035 CID_80579 | ||
| 0.337 | 0.003 | 0.337 | Toll-Like receptor 3 antagonist | 0.098 0.053 CID_80579 | ||
| 0.356 | 0.027 | 0.406 | Interleukin agonist | 0.406 0.018 CID_80579 | CID_80579 | |
| 0.348 | 0.023 | 0.348 | ErbB-1 antagonist | 0.191 0.099 CID_80579 | ||
| 0.329 | 0.007 | 0.329 | Succinate dehydrogenase inhibitor | 0.299 0.011 CID_80579 | ||
| 0.343 | 0.031 | 0.343 | Sigma receptor agonist | |||
| 0.333 | 0.025 | 0.333 | MAP kinase kinase 2 inhibitor | 0.233 0.062 CID_80579 | ||
| 0.309 | 0.003 | 0.309 | HIV-1 integrase (Overall Integration) inhibitor | 0.178 0.017 CID_80579 | ||
| 0.311 | 0.007 | 0.311 | Carbonic anhydrase XV inhibitor | 0.184 0.021 CID_80579 | ||
| 0.359 | 0.061 | 0.359 | Cholesterol antagonist | 0.299 0.092 CID_80579 | ||
| 0.304 | 0.006 | 0.304 | MAP kinase kinase 3 inhibitor | 0.186 0.168 CID_80579 | ||
| 0.292 | 0.003 | 0.292 | Sodium/calcium exchanger inhibitor | 0.094 0.006 CID_80579 | ||
| 0.295 | 0.019 | 0.295 | Amylase inhibitor | 0.153 0.063 CID_80579 | ||
| 0.39 | 0.117 | 0.49 | Caspase 9 stimulant | 0.49 0.064 CID_80579 | CID_80579 | |
| 0.28 | 0.007 | 0.28 | GABA C receptor rho-2 antagonist | 0.185 0.038 CID_80579 | ||
| 0.326 | 0.057 | 0.326 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.315 0.06 CID_80579 | ||
| 0.277 | 0.012 | 0.277 | Cystathionine beta-synthase inhibitor | 0.14 0.045 CID_80579 | ||
| 0.284 | 0.022 | 0.284 | Amyloid beta precursor protein antagonist | 0.197 0.059 CID_80579 | ||
| 0.275 | 0.019 | 0.275 | Nitric-oxide synthase stimulant | 0.241 0.039 CID_80579 | ||
| 0.265 | 0.011 | 0.285 | 5 Hydroxytryptamine 3E antagonist | 0.285 0.006 CID_80579 | CID_80579 | |
| 0.267 | 0.014 | 0.267 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.196 0.023 CID_80579 | ||
| 0.294 | 0.041 | 0.294 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | |||
| 0.35 | 0.099 | 0.35 | 15-Lipoxygenase inhibitor | 0.257 0.159 CID_80579 | ||
| 0.256 | 0.01 | 0.256 | Platelet activating factor alpha antagonist | 0.193 0.018 CID_80579 | ||
| 0.281 | 0.036 | 0.281 | RNA-directed DNA polymerase inhibitor | 0.19 0.115 CID_80579 | ||
| 0.26 | 0.015 | 0.295 | Hexokinase inhibitor | 0.295 0.011 CID_80579 | CID_80579 | |
| 0.251 | 0.009 | 0.251 | Carbonic anhydrase III inhibitor | 0.213 0.014 CID_80579 | ||
| 0.245 | 0.004 | 0.245 | Leukotriene A4 hydrolase inhibitor | 0.152 0.005 CID_80579 | ||
| 0.255 | 0.022 | 0.518 | Alpha-N-acetylglucosaminidase inhibitor | 0.518 0.005 CID_80579 | CID_80579 | |
| 0.239 | 0.007 | 0.239 | GABA C receptor antagonist | 0.113 0.06 CID_80579 | ||
| 0.278 | 0.047 | 0.304 | 5 Hydroxytryptamine 1E antagonist | 0.304 0.027 CID_80579 | CID_80579 | |
| 0.23 | 0.005 | 0.23 | GABA C receptor rho-1 antagonist | 0.117 0.043 CID_80579 | ||
| 0.258 | 0.033 | 0.258 | I kappa B kinase epsilon inhibitor | 0.171 0.098 CID_80579 | ||
| 0.239 | 0.015 | 0.295 | Ferrochelatase inhibitor | 0.295 0.008 CID_80579 | CID_80579 | |
| 0.302 | 0.078 | 0.302 | 12-Lipoxygenase inhibitor | 0.293 0.083 CID_80579 | ||
| 0.233 | 0.012 | 0.233 | Nav1.6 sodium channel blocker | 0.142 0.064 CID_80579 | ||
| 0.261 | 0.04 | 0.261 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.19 0.084 CID_80579 | ||
| 0.273 | 0.054 | 0.273 | DNA synthesis inhibitor | 0.175 0.161 CID_80579 | ||
| 0.246 | 0.028 | 0.246 | Vascular endothelial growth factor 3 antagonist | 0.215 0.036 CID_80579 | ||
| 0.236 | 0.018 | 0.236 | MAP kinase kinase inhibitor | 0.152 0.05 CID_80579 | ||
| 0.252 | 0.036 | 0.252 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.128 0.094 CID_80579 | ||
| 0.301 | 0.093 | 0.301 | Transcription factor NF kappa B inhibitor | 0.239 0.135 CID_80579 | ||
| 0.218 | 0.01 | 0.218 | 5 Hydroxytryptamine 3A agonist | 0.134 0.045 CID_80579 | ||
| 0.218 | 0.014 | 0.218 | CF transmembrane conductance regulator agonist | 0.196 0.024 CID_80579 | ||
| 0.244 | 0.041 | 0.244 | LIM domain kinase 1 inhibitor | 0.19 0.068 CID_80579 | ||
| 0.22 | 0.02 | 0.22 | Catenin beta inhibitor | 0.167 0.071 CID_80579 | ||
| 0.201 | 0.004 | 0.201 | GABA aminotransferase inhibitor | 0.097 0.029 CID_80579 | ||
| 0.2 | 0.005 | 0.2 | MAP kinase kinase 1 inhibitor | 0.157 0.014 CID_80579 | ||
| 0.225 | 0.031 | 0.225 | Lck kinase inhibitor | |||
| 0.26 | 0.068 | 0.298 | Gastrin inhibitor | 0.298 0.034 CID_80579 | CID_80579 | |
| 0.206 | 0.016 | 0.206 | Check point kinase 2 inhibitor | 0.099 0.066 CID_80579 | ||
| 0.336 | 0.146 | 0.346 | MAP kinase 1 inhibitor | 0.346 0.139 CID_80579 | CID_80579 | |
| 0.194 | 0.005 | 0.194 | Glutamate release inhibitor | 0.087 0.07 CID_80579 | ||
| 0.203 | 0.014 | 0.203 | Adenylate kinase inhibitor | 0.118 0.046 CID_80579 | ||
| 0.283 | 0.095 | 0.318 | Sodium/bile acid cotransporter inhibitor | 0.318 0.063 CID_80579 | CID_80579 | |
| 0.208 | 0.02 | 0.208 | Cathepsin H inhibitor | 0.163 0.038 CID_80579 | ||
| 0.301 | 0.114 | 0.456 | Calpain 2 inhibitor | 0.456 0.037 CID_80579 | CID_80579 | |
| 0.226 | 0.039 | 0.226 | Tumour necrosis factor antagonist | |||
| 0.213 | 0.026 | 0.213 | Toll-Like receptor antagonist | 0.113 0.097 CID_80579 | ||
| 0.193 | 0.008 | 0.193 | DOPA decarboxylase inhibitor | 0.128 0.037 CID_80579 | ||
| 0.198 | 0.013 | 0.198 | Interleukin 8 antagonist | 0.137 0.044 CID_80579 | ||
| 0.198 | 0.013 | 0.198 | Carbonic anhydrase VI inhibitor | 0.093 0.044 CID_80579 | ||
| 0.266 | 0.082 | 0.296 | Insulysin inhibitor | 0.296 0.061 CID_80579 | CID_80579 | |
| 0.211 | 0.028 | 0.211 | Interleukin 1 antagonist | 0.123 0.084 CID_80579 | ||
| 0.236 | 0.053 | 0.236 | TRKC antagonist | |||
| 0.2 | 0.018 | 0.236 | UDP-glucose 4-epimerase inhibitor | 0.236 0.014 CID_80579 | CID_80579 | |
| 0.223 | 0.042 | 0.223 | Histone acetyltransferase inhibitor | 0.164 0.121 CID_80579 | ||
| 0.206 | 0.025 | 0.206 | Platelet activating factor antagonist | 0.113 0.068 CID_80579 | ||
| 0.196 | 0.015 | 0.196 | Adenylate cyclase stimulant | 0.139 0.083 CID_80579 | ||
| 0.23 | 0.049 | 0.23 | Focal adhesion kinase 2 inhibitor | 0.186 0.081 CID_80579 | ||
| 0.191 | 0.011 | 0.191 | NADH dehydrogenase inhibitor | 0.106 0.038 CID_80579 | ||
| 0.198 | 0.019 | 0.272 | Cyclooxygenase 3 inhibitor | 0.272 0.007 CID_80579 | CID_80579 | |
| 0.206 | 0.027 | 0.206 | MAP kinase kinase 5 inhibitor | 0.176 0.07 CID_80579 | ||
| 0.23 | 0.052 | 0.23 | Non-steroidal antiinflammatory agent | 0.18 0.087 CID_80579 | ||
| 0.205 | 0.028 | 0.205 | Mannose-6-phosphate isomerase inhibitor | 0.121 0.1 CID_80579 | ||
| 0.192 | 0.015 | 0.23 | Sphingosine 1-phosphate receptor 5 antagonist | 0.23 0.005 CID_80579 | CID_80579 | |
| 0.203 | 0.03 | 0.203 | Arachidonic acid antagonist | 0.162 0.074 CID_80579 | ||
| 0.204 | 0.031 | 0.204 | Anesthetic local | 0.137 0.055 CID_80579 | ||
| 0.204 | 0.033 | 0.204 | Nav1.2 sodium channel blocker | 0.179 0.043 CID_80579 | ||
| 0.177 | 0.008 | 0.177 | Alcohol oxidase inhibitor | 0.151 0.01 CID_80579 | ||
| 0.237 | 0.069 | 0.281 | Neuropeptide Y2 antagonist | 0.281 0.03 CID_80579 | CID_80579 | |
| 0.194 | 0.026 | 0.194 | Platelet activating factor beta antagonist | |||
| 0.179 | 0.011 | 0.179 | Electrolyte absorption antagonist | 0.16 0.016 CID_80579 | ||
| 0.179 | 0.012 | 0.179 | Platelet growth factor antagonist | 0.113 0.033 CID_80579 | ||
| 0.229 | 0.063 | 0.229 | Platelet aggregation inhibitor | 0.151 0.128 CID_80579 | ||
| 0.22 | 0.055 | 0.22 | Insulin sensitizer | 0.211 0.063 CID_80579 | ||
| 0.199 | 0.036 | 0.199 | Toll-Like receptor 9 antagonist | |||
| 0.178 | 0.015 | 0.178 | Creatine kinase inhibitor | 0.127 0.036 CID_80579 | ||
| 0.178 | 0.015 | 0.178 | Histidine decarboxylase inhibitor | 0.072 0.048 CID_80579 | ||
| 0.224 | 0.062 | 0.224 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.182 | 0.023 | 0.182 | Nav1.1 sodium channel blocker | 0.1 0.066 CID_80579 | ||
| 0.163 | 0.004 | 0.163 | D-Ala-D-Ala ligase inhibitor | 0.118 0.014 CID_80579 | ||
| 0.2 | 0.042 | 0.2 | Protein kinase stimulant | 0.172 0.054 CID_80579 | ||
| 0.215 | 0.058 | 0.215 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.175 | 0.018 | 0.206 | Papain-like protease (SARS coronavirus) inhibitor | 0.206 0.009 CID_80579 | CID_80579 | |
| 0.17 | 0.015 | 0.17 | Triose-phosphate isomerase inhibitor | 0.135 0.025 CID_80579 | ||
| 0.174 | 0.02 | 0.232 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.232 0.012 CID_80579 | CID_80579 | |
| 0.163 | 0.01 | 0.163 | Acetylcholine release stimulant | 0.123 0.044 CID_80579 | ||
| 0.169 | 0.017 | 0.169 | Porphobilinogen synthase inhibitor | 0.117 0.029 CID_80579 | ||
| 0.17 | 0.018 | 0.17 | DNA repair enzyme inhibitor | 0.138 0.044 CID_80579 | ||
| 0.172 | 0.02 | 0.212 | Sphingosine 1-phosphate receptor 2 antagonist | 0.212 0.005 CID_80579 | CID_80579 | |
| 0.177 | 0.025 | 0.177 | Beta amyloid protein antagonist | |||
| 0.16 | 0.009 | 0.16 | Purinergic P2X2 antagonist | |||
| 0.198 | 0.048 | 0.198 | Protein kinase (CK1) gamma 3 inhibitor | |||
| 0.159 | 0.012 | 0.176 | Nav1.8 sodium channel blocker | 0.176 0.01 CID_80579 | CID_80579 | |
| 0.187 | 0.041 | 0.187 | Tubulin antagonist | |||
| 0.15 | 0.005 | 0.15 | Granulocyte macrophage colony stimulating factor agonist | 0.104 0.03 CID_80579 | ||
| 0.187 | 0.042 | 0.187 | Vascular endothelial growth factor antagonist | 0.109 0.075 CID_80579 | ||
| 0.164 | 0.019 | 0.164 | Carbonic anhydrase XIII inhibitor | 0.087 0.045 CID_80579 | ||
| 0.153 | 0.01 | 0.153 | Myeloperoxidase inhibitor | |||
| 0.163 | 0.02 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.142 0.065 CID_80579 | ||
| 0.18 | 0.041 | 0.18 | Sodium channel blocker | 0.12 0.085 CID_80579 | ||
| 0.168 | 0.029 | 0.168 | Interleukin 1b antagonist | 0.138 0.049 CID_80579 | ||
| 0.23 | 0.093 | 0.23 | DNA damaging | |||
| 0.162 | 0.025 | 0.197 | Death-associated protein kinase 1 inhibitor | 0.197 0.008 CID_80579 | CID_80579 | |
| 0.152 | 0.019 | 0.152 | Protein kinase C zeta inhibitor | |||
| 0.153 | 0.021 | 0.153 | Nitric-oxide synthase inhibitor | |||
| 0.256 | 0.124 | 0.256 | Prostaglandin dehydrogenase inhibitor | |||
| 0.14 | 0.008 | 0.14 | Purinergic P2X1 antagonist | 0.071 0.031 CID_80579 | ||
| 0.145 | 0.013 | 0.145 | Phenylalanine 4-hydroxylase inhibitor | 0.081 0.037 CID_80579 | ||
| 0.177 | 0.045 | 0.19 | Cytokine production inhibitor | 0.19 0.039 CID_80579 | CID_80579 | |
| 0.281 | 0.15 | 0.281 | Antibacterial | |||
| 0.207 | 0.076 | 0.207 | Psychostimulant | |||
| 0.18 | 0.05 | 0.18 | Interferon gamma antagonist | 0.159 0.068 CID_80579 | ||
| 0.216 | 0.086 | 0.216 | Angiogenesis stimulant | |||
| 0.188 | 0.059 | 0.272 | 3C-like protease (Human coronavirus) inhibitor | 0.272 0.019 CID_80579 | CID_80579 | |
| 0.17 | 0.043 | 0.17 | Vascular endothelial growth factor 2 antagonist | 0.092 0.078 CID_80579 | ||
| 0.168 | 0.041 | 0.168 | Neuropeptide Y1 antagonist | 0.16 0.051 CID_80579 | ||
| 0.169 | 0.043 | 0.169 | Sodium channel (voltage-gated) blocker | 0.128 0.075 CID_80579 | ||
| 0.236 | 0.11 | 0.236 | Lipoxygenase inhibitor | 0.189 0.153 CID_80579 | ||
| 0.23 | 0.105 | 0.25 | Immunostimulant | 0.25 0.096 CID_80579 | CID_80579 | |
| 0.13 | 0.006 | 0.156 | NMDA receptor glycine site agonist | 0.156 0.004 CID_80579 | CID_80579 | |
| 0.126 | 0.004 | 0.126 | Glutamate (mGluR7) antagonist | 0.097 0.013 CID_80579 | ||
| 0.141 | 0.02 | 0.141 | Phosphofructokinase-1 inhibitor | |||
| 0.162 | 0.041 | 0.162 | Alkylator | 0.121 0.067 CID_80579 | ||
| 0.148 | 0.029 | 0.148 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.109 0.047 CID_80579 | ||
| 0.129 | 0.01 | 0.143 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.143 0.008 CID_80579 | CID_80579 | |
| 0.174 | 0.056 | 0.175 | Neurotensin receptor agonist | 0.175 0.055 CID_80579 | CID_80579 | |
| 0.143 | 0.024 | 0.143 | TIE antagonist | |||
| 0.2 | 0.082 | 0.2 | Anticonvulsant | |||
| 0.138 | 0.021 | 0.138 | Thioredoxin inhibitor | 0.095 0.054 CID_80579 | ||
| 0.141 | 0.024 | 0.141 | TIE-2 antagonist | |||
| 0.136 | 0.02 | 0.136 | NMDA 2 receptor antagonist | 0.063 0.058 CID_80579 | ||
| 0.124 | 0.008 | 0.124 | Estrogen-related receptor beta agonist | 0.101 0.024 CID_80579 | ||
| 0.19 | 0.075 | 0.19 | DNA methyltransferase I inhibitor | 0.179 0.08 CID_80579 | ||
| 0.134 | 0.019 | 0.134 | Lanosterol 14 alpha demethylase inhibitor | 0.092 0.068 CID_80579 | ||
| 0.14 | 0.025 | 0.14 | Hepatocyte growth factor antagonist | 0.09 0.063 CID_80579 | ||
| 0.126 | 0.012 | 0.126 | Carbonic anhydrase VB inhibitor | 0.071 0.027 CID_80579 | ||
| 0.124 | 0.01 | 0.124 | NMDA 2C receptor antagonist | 0.076 0.028 CID_80579 | ||
| 0.153 | 0.039 | 0.153 | Heat shock protein 70 antagonist | 0.152 0.042 CID_80579 | ||
| 0.128 | 0.014 | 0.128 | Carbamoyl phosphate synthetase inhibitor | 0.057 0.046 CID_80579 | ||
| 0.231 | 0.118 | 0.231 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.133 | 0.021 | 0.133 | Histamine N-methyltransferase inhibitor | |||
| 0.124 | 0.012 | 0.148 | NMDA receptor agonist | 0.148 0.008 CID_80579 | CID_80579 | |
| 0.149 | 0.037 | 0.19 | Falcipain 3 inhibitor | 0.19 0.021 CID_80579 | CID_80579 | |
| 0.13 | 0.019 | 0.13 | Carbonic anhydrase V inhibitor | 0.117 0.022 CID_80579 | ||
| 0.202 | 0.092 | 0.202 | Cyclic AMP phosphodiesterase inhibitor | 0.158 0.138 CID_80579 | ||
| 0.114 | 0.004 | 0.114 | Dihydropteroate synthase inhibitor | 0.069 0.008 CID_80579 | ||
| 0.114 | 0.005 | 0.114 | Epithelial sodium channel blocker | 0.057 0.033 CID_80579 | ||
| 0.175 | 0.066 | 0.175 | Heat shock protein 90 alpha antagonist | 0.15 0.087 CID_80579 | ||
| 0.166 | 0.058 | 0.166 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.162 | 0.055 | 0.162 | Hemostatic | 0.156 0.061 CID_80579 | ||
| 0.123 | 0.017 | 0.123 | Bile acid receptor antagonist | 0.109 0.033 CID_80579 | ||
| 0.152 | 0.046 | 0.152 | Monophenol monooxygenase inhibitor | 0.122 0.06 CID_80579 | ||
| 0.135 | 0.029 | 0.135 | DNA directed RNA polymerase inhibitor | |||
| 0.114 | 0.007 | 0.114 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.061 CID_80579 | ||
| 0.12 | 0.014 | 0.12 | Biliverdin reductase inhibitor | 0.071 0.031 CID_80579 | ||
| 0.142 | 0.036 | 0.142 | Photosensitizer | 0.116 0.062 CID_80579 | ||
| 0.244 | 0.141 | 0.244 | Vasodilator, coronary | |||
| 0.164 | 0.061 | 0.164 | Heat shock protein 90 antagonist | 0.122 0.111 CID_80579 | ||
| 0.11 | 0.007 | 0.11 | Glutamate (mGluR6) antagonist | 0.077 0.028 CID_80579 | ||
| 0.12 | 0.018 | 0.12 | Carbonic anhydrase VA inhibitor | 0.113 0.02 CID_80579 | ||
| 0.138 | 0.036 | 0.138 | Nav1.5 sodium channel blocker | 0.102 0.081 CID_80579 | ||
| 0.166 | 0.065 | 0.166 | Cyclin-dependent kinase 8 inhibitor | 0.148 0.081 CID_80579 | ||
| 0.126 | 0.025 | 0.126 | AXL receptor tyrosine kinase inhibitor | |||
| 0.127 | 0.027 | 0.127 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.059 CID_80579 | ||
| 0.158 | 0.058 | 0.158 | Cell wall synthesis inhibitor | 0.157 0.059 CID_80579 | ||
| 0.184 | 0.085 | 0.184 | Ca2+/calmodulin-dependent protein kinase inhibitor | |||
| 0.133 | 0.034 | 0.133 | Potassium channel (Ca-activated) activator | |||
| 0.113 | 0.015 | 0.113 | Glycine receptor agonist | |||
| 0.12 | 0.023 | 0.12 | Glutamate dehydrogenase inhibitor | 0.085 0.04 CID_80579 | ||
| 0.146 | 0.048 | 0.146 | Adenylate cyclase inhibitor | |||
| 0.151 | 0.054 | 0.151 | NADPH oxidase inhibitor | 0.124 0.078 CID_80579 | ||
| 0.169 | 0.071 | 0.169 | Src kinase inhibitor | |||
| 0.102 | 0.005 | 0.131 | Dihydroorotate oxidase inhibitor | 0.131 0.003 CID_80579 | CID_80579 | |
| 0.186 | 0.089 | 0.186 | DNA methylase inhibitor | 0.162 0.107 CID_80579 | ||
| 0.141 | 0.044 | 0.141 | Vascular endothelial growth factor 1 antagonist | |||
| 0.14 | 0.043 | 0.18 | Sphingosine 1-phosphate receptor 4 antagonist | 0.18 0.014 CID_80579 | CID_80579 | |
| 0.186 | 0.089 | 0.186 | Pyruvate kinase inhibitor | 0.144 0.12 CID_80579 | ||
| 0.128 | 0.032 | 0.128 | Anabolic | 0.116 0.043 CID_80579 | ||
| 0.139 | 0.043 | 0.139 | Aminopeptidase B inhibitor | 0.108 0.06 CID_80579 | ||
| 0.121 | 0.025 | 0.121 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | |||
| 0.108 | 0.013 | 0.108 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.054 0.042 CID_80579 | ||
| 0.102 | 0.008 | 0.102 | Exportin-1 inhibitor | 0.08 0.025 CID_80579 | ||
| 0.11 | 0.017 | 0.11 | Argininosuccinate synthase inhibitor | 0.051 0.045 CID_80579 | ||
| 0.112 | 0.02 | 0.112 | Sphingosine 1-phosphate receptor 4 agonist | 0.063 0.051 CID_80579 | ||
| 0.118 | 0.026 | 0.118 | Inducible nitric-oxide synthase inhibitor | |||
| 0.102 | 0.01 | 0.122 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.122 0.005 CID_80579 | CID_80579 | |
| 0.115 | 0.023 | 0.115 | Glutamate decarboxylase inhibitor | 0.069 0.057 CID_80579 | ||
| 0.163 | 0.071 | 0.163 | Polo-like kinase-3 inhibitor | |||
| 0.228 | 0.137 | 0.265 | Ca(v)3.3 blocker | 0.265 0.079 CID_80579 | CID_80579 | |
| 0.118 | 0.027 | 0.118 | I kappa B kinase inhibitor | 0.081 0.06 CID_80579 | ||
| 0.126 | 0.037 | 0.126 | Sphingomyelinase inhibitor | 0.116 0.044 CID_80579 | ||
| 0.141 | 0.053 | 0.141 | Aldehyde dehydrogenase inhibitor | |||
| 0.116 | 0.027 | 0.116 | Macrophage migration inhibitory factor inhibitor | |||
| 0.093 | 0.005 | 0.093 | Ryanodine receptor antagonist | 0.055 0.054 CID_80579 | ||
| 0.123 | 0.035 | 0.123 | Phosphodiesterase 7B inhibitor | |||
| 0.131 | 0.045 | 0.153 | Mucolytic | 0.153 0.03 CID_80579 | CID_80579 | |
| 0.192 | 0.105 | 0.192 | Antiamyloidogenic | |||
| 0.101 | 0.015 | 0.101 | Bruton tyrosine kinase inhibitor | |||
| 0.101 | 0.016 | 0.101 | Acyl-CoA dehydrogenase inhibitor | 0.064 0.03 CID_80579 | ||
| 0.107 | 0.023 | 0.107 | Raf kinase C inhibitor | 0.085 0.03 CID_80579 | ||
| 0.098 | 0.015 | 0.098 | MAP kinase kinase 7 inhibitor | 0.082 0.04 CID_80579 | ||
| 0.116 | 0.033 | 0.116 | ABCA1 expression enhancer | |||
| 0.138 | 0.056 | 0.162 | Nav1.3 sodium channel blocker | 0.162 0.041 CID_80579 | CID_80579 | |
| 0.178 | 0.097 | 0.178 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.095 | 0.014 | 0.095 | I kappa B kinase 2 inhibitor | 0.068 0.035 CID_80579 | ||
| 0.223 | 0.142 | 0.412 | Thyroid hormone antagonist | 0.412 0.052 CID_80579 | CID_80579 | |
| 0.094 | 0.015 | 0.094 | NMDA 2A receptor antagonist | |||
| 0.097 | 0.019 | 0.097 | GABA B receptor agonist | 0.087 0.03 CID_80579 | ||
| 0.116 | 0.038 | 0.116 | NMDA receptor antagonist | |||
| 0.097 | 0.02 | 0.097 | Secretase beta inhibitor | 0.094 0.022 CID_80579 | ||
| 0.099 | 0.022 | 0.099 | Aromatase inhibitor | |||
| 0.127 | 0.049 | 0.135 | Transcription factor STAT6 inhibitor | 0.135 0.037 CID_80579 | CID_80579 | |
| 0.195 | 0.118 | 0.264 | Calpain inhibitor | 0.264 0.053 CID_80579 | CID_80579 | |
| 0.091 | 0.013 | 0.091 | Carbonic anhydrase XIV inhibitor | 0.069 0.021 CID_80579 | ||
| 0.142 | 0.065 | 0.142 | Alkaline phosphatase inhibitor | 0.117 0.089 CID_80579 | ||
| 0.114 | 0.037 | 0.147 | Glutamate (mGluR7) agonist | 0.147 0.013 CID_80579 | CID_80579 | |
| 0.146 | 0.07 | 0.146 | Protein kinase (CK1) gamma inhibitor | |||
| 0.16 | 0.084 | 0.16 | Tyrosine kinase inhibitor | |||
| 0.082 | 0.006 | 0.082 | Dopamine D5 agonist | 0.036 0.034 CID_80579 | ||
| 0.204 | 0.129 | 0.344 | Transcription factor STAT3 inhibitor | 0.344 0.035 CID_80579 | CID_80579 | |
| 0.17 | 0.095 | 0.17 | Amyloid beta aggregation inhibitor | |||
| 0.087 | 0.012 | 0.087 | Transcription factor RelA inhibitor | 0.065 0.041 CID_80579 | ||
| 0.093 | 0.019 | 0.093 | Potassium channel (ATP-sensitive) blocker | 0.08 0.028 CID_80579 | ||
| 0.14 | 0.066 | 0.14 | Farnesoid X receptor antagonist | 0.128 0.086 CID_80579 | ||
| 0.08 | 0.008 | 0.08 | Adenylate cyclase 1 inhibitor | |||
| 0.081 | 0.009 | 0.085 | Lysophosphatidic acid 3 receptor antagonist | 0.085 0.008 CID_80579 | CID_80579 | |
| 0.083 | 0.011 | 0.083 | Lysine-specific demethylase 1A inhibitor | |||
| 0.079 | 0.008 | 0.079 | Fructose-1,6-bisphosphatase inhibitor | 0.043 0.033 CID_80579 | ||
| 0.111 | 0.04 | 0.122 | Potassium channel (Voltage-sensitive) activator | 0.122 0.03 CID_80579 | CID_80579 | |
| 0.1 | 0.029 | 0.1 | Interferon agonist | |||
| 0.084 | 0.012 | 0.084 | Aconitate hydratase inhibitor | |||
| 0.075 | 0.004 | 0.075 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.04 0.034 CID_80579 | ||
| 0.147 | 0.077 | 0.147 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.085 | 0.014 | 0.085 | Cyclin D1 inhibitor | 0.082 0.016 CID_80579 | ||
| 0.083 | 0.013 | 0.083 | Topoisomerase II beta inhibitor | 0.066 0.018 CID_80579 | ||
| 0.077 | 0.007 | 0.077 | Immunoglobulin Fc receptor antagonist | 0.063 0.019 CID_80579 | ||
| 0.084 | 0.015 | 0.084 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.12 | 0.052 | 0.12 | MAO A inhibitor | 0.107 0.06 CID_80579 | ||
| 0.101 | 0.033 | 0.101 | Histamine H2 receptor antagonist | |||
| 0.072 | 0.005 | 0.072 | Glutamate (mGluR8) agonist | 0.044 0.016 CID_80579 | ||
| 0.1 | 0.033 | 0.1 | mTOR complex 2 inhibitor | |||
| 0.134 | 0.068 | 0.134 | MAO inhibitor | 0.106 0.084 CID_80579 | ||
| 0.145 | 0.079 | 0.145 | Phospholipase A2 inhibitor | 0.14 0.086 CID_80579 | ||
| 0.098 | 0.033 | 0.098 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.085 | 0.02 | 0.085 | GABA receptor antagonist | |||
| 0.08 | 0.015 | 0.08 | Sphingosine kinase 2 inhibitor | |||
| 0.085 | 0.02 | 0.085 | GABA A receptor antagonist | |||
| 0.118 | 0.054 | 0.118 | Protein kinase C gamma inhibitor | |||
| 0.071 | 0.006 | 0.071 | Dihydrofolate reductase inhibitor | |||
| 0.073 | 0.009 | 0.073 | Estrogen-related receptor alpha antagonist | |||
| 0.11 | 0.046 | 0.11 | Prolactin inhibitor | 0.089 0.068 CID_80579 | ||
| 0.117 | 0.053 | 0.122 | Expectorant | 0.122 0.049 CID_80579 | CID_80579 | |
| 0.116 | 0.053 | 0.119 | Electron transport complex I inhibitor | 0.119 0.048 CID_80579 | CID_80579 | |
| 0.09 | 0.027 | 0.09 | Acetylcholine M5 receptor agonist | 0.077 0.037 CID_80579 | ||
| 0.079 | 0.016 | 0.083 | Factor IXa inhibitor | 0.083 0.015 CID_80579 | CID_80579 | |
| 0.076 | 0.013 | 0.076 | CD45 antagonist | 0.06 0.022 CID_80579 | ||
| 0.096 | 0.035 | 0.096 | Raf kinase inhibitor | 0.088 0.04 CID_80579 | ||
| 0.218 | 0.156 | 0.286 | Vasodilator, peripheral | 0.286 0.104 CID_80579 | CID_80579 | |
| 0.147 | 0.086 | 0.147 | Melanin inhibitor | 0.139 0.098 CID_80579 | ||
| 0.115 | 0.056 | 0.115 | Nav1.4 sodium channel blocker | 0.106 0.068 CID_80579 | ||
| 0.119 | 0.061 | 0.119 | Microtubule formation inhibitor | 0.101 0.089 CID_80579 | ||
| 0.076 | 0.019 | 0.076 | Calcium channel P-type blocker | |||
| 0.072 | 0.015 | 0.072 | NMDA receptor subunit 3B antagonist | 0.041 0.033 CID_80579 | ||
| 0.082 | 0.025 | 0.082 | 5 Hydroxytryptamine 3 agonist | |||
| 0.198 | 0.142 | 0.343 | Transcription factor STAT inhibitor | 0.343 0.037 CID_80579 | CID_80579 | |
| 0.105 | 0.051 | 0.126 | Interleukin 1 beta converting enzyme inhibitor | 0.126 0.03 CID_80579 | CID_80579 | |
| 0.064 | 0.01 | 0.077 | Benzodiazepine antagonist | 0.077 0.005 CID_80579 | CID_80579 | |
| 0.095 | 0.041 | 0.095 | Adrenaline agonist | 0.081 0.056 CID_80579 | ||
| 0.204 | 0.15 | 0.401 | Thyroid hormone beta antagonist | 0.401 0.053 CID_80579 | CID_80579 | |
| 0.134 | 0.081 | 0.134 | Activin receptor-like kinase 2 inhibitor | |||
| 0.078 | 0.025 | 0.078 | Alpha 2 adrenoreceptor agonist | |||
| 0.109 | 0.057 | 0.109 | Toll-Like receptor 4 antagonist | 0.096 0.076 CID_80579 | ||
| 0.076 | 0.024 | 0.076 | Heat shock protein 90 beta antagonist | |||
| 0.102 | 0.05 | 0.102 | Alcohol dehydrogenase inhibitor | |||
| 0.118 | 0.067 | 0.118 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.077 | 0.026 | 0.094 | Beta 3 adrenoreceptor antagonist | 0.094 0.017 CID_80579 | CID_80579 | |
| 0.101 | 0.05 | 0.101 | Phosphodiesterase 6D inhibitor | 0.096 0.06 CID_80579 | ||
| 0.065 | 0.015 | 0.065 | NMDA receptor subunit 3A antagonist | |||
| 0.073 | 0.023 | 0.073 | Urokinase inhibitor | |||
| 0.097 | 0.048 | 0.097 | Pim-3 kinase inhibitor | |||
| 0.135 | 0.086 | 0.157 | Pregnane X receptor agonist | 0.157 0.041 CID_80579 | CID_80579 | |
| 0.15 | 0.101 | 0.191 | ATPase inhibitor | 0.191 0.045 CID_80579 | CID_80579 | |
| 0.071 | 0.023 | 0.071 | Toll-Like receptor 8 antagonist | |||
| 0.097 | 0.049 | 0.138 | Androgen antagonist | 0.138 0.026 CID_80579 | CID_80579 | |
| 0.064 | 0.016 | 0.064 | Glucose-6-phosphate isomerase inhibitor | 0.051 0.029 CID_80579 | ||
| 0.089 | 0.042 | 0.089 | CYP2A6 inhibitor | |||
| 0.076 | 0.028 | 0.076 | Interferon inducer | |||
| 0.059 | 0.011 | 0.059 | Alpha 1d adrenoreceptor agonist | |||
| 0.112 | 0.064 | 0.112 | Alpha 2b adrenoreceptor antagonist | |||
| 0.06 | 0.013 | 0.06 | Cytokine production stimulant | 0.046 0.042 CID_80579 | ||
| 0.079 | 0.032 | 0.079 | Histone deacetylase inhibitor | 0.078 0.032 CID_80579 | ||
| 0.085 | 0.038 | 0.085 | Aminopeptidase I inhibitor | 0.072 0.051 CID_80579 | ||
| 0.122 | 0.076 | 0.122 | Acetylcholinesterase inhibitor | |||
| 0.07 | 0.025 | 0.07 | Botulinum neurotoxin type A inhibitor | 0.068 0.027 CID_80579 | ||
| 0.118 | 0.073 | 0.118 | MAP kinase 12 inhibitor | |||
| 0.243 | 0.199 | 0.243 | MAP kinase kinase 6 inhibitor | |||
| 0.07 | 0.026 | 0.07 | Gonadotropin-releasing hormone receptor agonist | |||
| 0.114 | 0.069 | 0.114 | Aurora-B kinase inhibitor | 0.107 0.074 CID_80579 | ||
| 0.089 | 0.044 | 0.127 | Glycine receptor antagonist | 0.127 0.015 CID_80579 | CID_80579 | |
| 0.121 | 0.077 | 0.168 | Toll-Like receptor 2 antagonist | 0.168 0.041 CID_80579 | CID_80579 | |
| 0.087 | 0.043 | 0.087 | T cell inhibitor | |||
| 0.094 | 0.05 | 0.094 | Ornithine decarboxylase inhibitor | |||
| 0.166 | 0.122 | 0.166 | Dyrk kinase inhibitor | |||
| 0.105 | 0.061 | 0.116 | Urease inhibitor | 0.116 0.049 CID_80579 | CID_80579 | |
| 0.062 | 0.019 | 0.069 | Oleamide hydrolase inhibitor | 0.069 0.016 CID_80579 | CID_80579 | |
| 0.122 | 0.079 | 0.122 | Cyclooxygenase 1 inhibitor | |||
| 0.069 | 0.026 | 0.069 | Heme oxygenase stimulant | 0.06 0.045 CID_80579 | ||
| 0.121 | 0.078 | 0.121 | RET inhibitor | |||
| 0.128 | 0.085 | 0.128 | Growth factor antagonist | |||
| 0.058 | 0.015 | 0.058 | AICAR transformylase inhibitor | 0.046 0.027 CID_80579 | ||
| 0.085 | 0.042 | 0.085 | Keratolytic | 0.079 0.051 CID_80579 | ||
| 0.08 | 0.038 | 0.08 | Alpha adrenoreceptor agonist | |||
| 0.057 | 0.015 | 0.057 | Glutamate (mGluR group III) antagonist | |||
| 0.094 | 0.052 | 0.094 | Phosphodiesterase I inhibitor | |||
| 0.069 | 0.027 | 0.077 | Sphingosine 1-phosphate receptor 3 antagonist | 0.077 0.02 CID_80579 | CID_80579 | |
| 0.101 | 0.059 | 0.101 | MAP kinase 8 inhibitor | |||
| 0.046 | 0.004 | 0.046 | Estrogen-related receptor gamma antagonist | 0.031 0.013 CID_80579 | ||
| 0.05 | 0.008 | 0.05 | Uridine phosphorylase inhibitor | 0.036 0.014 CID_80579 | ||
| 0.052 | 0.011 | 0.052 | Heme oxygenase inhibitor | |||
| 0.064 | 0.022 | 0.064 | Alpha-mannosidase inhibitor | 0.053 0.039 CID_80579 | ||
| 0.128 | 0.087 | 0.128 | CDC-like kinase 1 inhibitor | |||
| 0.052 | 0.011 | 0.052 | Glutamate (mGluR3) antagonist | |||
| 0.077 | 0.036 | 0.077 | Nav1.7 sodium channel blocker | |||
| 0.081 | 0.041 | 0.081 | HIV-1 reverse transcriptase inhibitor | |||
| 0.067 | 0.027 | 0.067 | Beta 2 adrenoreceptor agonist | 0.065 0.032 CID_80579 | ||
| 0.058 | 0.018 | 0.058 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.101 | 0.061 | 0.101 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.056 | 0.016 | 0.056 | Glutamate (mGluR4) antagonist | |||
| 0.056 | 0.017 | 0.056 | Geranyltranstransferase inhibitor | |||
| 0.08 | 0.041 | 0.084 | Vanilloid 4 agonist | 0.084 0.035 CID_80579 | CID_80579 | |
| 0.046 | 0.007 | 0.046 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.052 | 0.013 | 0.065 | Diamine oxidase inhibitor | 0.065 0.008 CID_80579 | CID_80579 | |
| 0.068 | 0.03 | 0.098 | Histone deacetylase SIRT3 inhibitor | 0.098 0.01 CID_80579 | CID_80579 | |
| 0.139 | 0.101 | 0.139 | Mcl-1 antagonist | |||
| 0.057 | 0.02 | 0.068 | Cholesterol esterase inhibitor | 0.068 0.011 CID_80579 | CID_80579 | |
| 0.085 | 0.048 | 0.085 | Transforming growth factor beta 3 antagonist | |||
| 0.102 | 0.065 | 0.102 | MAP kinase kinase kinase inhibitor | 0.087 0.08 CID_80579 | ||
| 0.089 | 0.053 | 0.099 | Bcr-Abl kinase inhibitor | 0.099 0.042 CID_80579 | CID_80579 | |
| 0.056 | 0.02 | 0.056 | Dopamine beta hydroxylase inhibitor | |||
| 0.112 | 0.075 | 0.112 | Calcium channel N-type blocker | |||
| 0.046 | 0.01 | 0.046 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.109 | 0.074 | 0.109 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.074 | 0.038 | 0.074 | Fibroblast growth factor 2 antagonist | 0.057 0.056 CID_80579 | ||
| 0.076 | 0.041 | 0.139 | Amidase inhibitor | 0.139 0.011 CID_80579 | CID_80579 | |
| 0.13 | 0.095 | 0.134 | Thiol protease inhibitor | 0.134 0.09 CID_80579 | CID_80579 | |
| 0.045 | 0.01 | 0.055 | Benzodiazepine receptor peripheral-type antagonist | 0.055 0.005 CID_80579 | CID_80579 | |
| 0.055 | 0.02 | 0.055 | Mannosidase inhibitor | 0.041 0.038 CID_80579 | ||
| 0.053 | 0.019 | 0.053 | Histamine H2 receptor agonist | 0.039 0.036 CID_80579 | ||
| 0.059 | 0.025 | 0.059 | Phosphorylase inhibitor | 0.042 0.036 CID_80579 | ||
| 0.059 | 0.025 | 0.077 | Heparanase inhibitor | 0.077 0.008 CID_80579 | CID_80579 | |
| 0.084 | 0.05 | 0.097 | CC chemokine 5 receptor agonist | 0.097 0.026 CID_80579 | CID_80579 | |
| 0.065 | 0.031 | 0.065 | Maillard reaction inhibitor | |||
| 0.158 | 0.124 | 0.158 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | |||
| 0.067 | 0.034 | 0.067 | Phosphodiesterase 1C inhibitor | 0.058 0.054 CID_80579 | ||
| 0.072 | 0.04 | 0.072 | Bcl2 antagonist | |||
| 0.037 | 0.005 | 0.037 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.037 | 0.004 | 0.037 | Complement factor 1s inhibitor | 0.025 0.019 CID_80579 | ||
| 0.05 | 0.018 | 0.05 | Nerve growth factor antagonist | |||
| 0.044 | 0.012 | 0.044 | Free fatty acid receptor 1 antagonist | 0.032 0.026 CID_80579 | ||
| 0.12 | 0.088 | 0.126 | Vanilloid 1 agonist | 0.126 0.074 CID_80579 | CID_80579 | |
| 0.101 | 0.07 | 0.101 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.056 | 0.025 | 0.073 | Potassium channel (Inward rectifier) activator | 0.073 0.01 CID_80579 | CID_80579 | |
| 0.062 | 0.03 | 0.062 | Ornithine carbamoyltransferase inhibitor | |||
| 0.041 | 0.009 | 0.041 | Dopamine autoreceptor agonist | |||
| 0.109 | 0.078 | 0.109 | TRKA antagonist | |||
| 0.084 | 0.052 | 0.084 | Acetylcholine nicotinic agonist | 0.076 0.062 CID_80579 | ||
| 0.079 | 0.048 | 0.18 | Catalase inhibitor | 0.18 0.019 CID_80579 | CID_80579 | |
| 0.054 | 0.023 | 0.054 | Thymidylate synthase inhibitor | |||
| 0.049 | 0.018 | 0.049 | Plasmepsin II inhibitor | |||
| 0.042 | 0.011 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.089 | 0.058 | 0.092 | Bromodomain-containing protein 2 inhibitor | 0.092 0.051 CID_80579 | CID_80579 | |
| 0.077 | 0.047 | 0.084 | Adenosine A3 receptor antagonist | 0.084 0.039 CID_80579 | CID_80579 | |
| 0.112 | 0.082 | 0.112 | Epidermal growth factor receptor kinase inhibitor | |||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.045 | 0.015 | 0.045 | VCAM-1 antagonist | 0.04 0.026 CID_80579 | ||
| 0.128 | 0.098 | 0.128 | Acetylcholine M1 receptor antagonist | |||
| 0.034 | 0.004 | 0.037 | Factor XIII inhibitor | 0.037 0.004 CID_80579 | CID_80579 | |
| 0.044 | 0.015 | 0.044 | VCAM antagonist | 0.04 0.026 CID_80579 | ||
| 0.065 | 0.035 | 0.065 | Carbonic anhydrase IX inhibitor | 0.048 0.044 CID_80579 | ||
| 0.045 | 0.016 | 0.045 | Fumarate hydratase inhibitor | |||
| 0.043 | 0.014 | 0.043 | Potassium channel small-conductance Ca-activated activator | |||
| 0.053 | 0.024 | 0.07 | Potassium channel (ATP-sensitive) activator | 0.07 0.01 CID_80579 | CID_80579 | |
| 0.056 | 0.027 | 0.056 | Phosphodiesterase 7A inhibitor | |||
| 0.063 | 0.034 | 0.065 | Sphingosine kinase inhibitor | 0.065 0.031 CID_80579 | CID_80579 | |
| 0.045 | 0.016 | 0.045 | Phosphoglycerate kinase inhibitor | |||
| 0.132 | 0.103 | 0.132 | MAP kinase 3 inhibitor | 0.129 0.108 CID_80579 | ||
| 0.099 | 0.071 | 0.099 | AMP-activated protein kinase stimulant | |||
| 0.117 | 0.089 | 0.117 | Tyrosine-protein kinase receptor antagonist | |||
| 0.075 | 0.048 | 0.075 | Cathepsin G inhibitor | |||
| 0.046 | 0.019 | 0.046 | Kainate receptor agonist | |||
| 0.036 | 0.009 | 0.036 | MAP3K8 inhibitor | 0.031 0.016 CID_80579 | ||
| 0.066 | 0.039 | 0.066 | Adenosine A2a receptor antagonist | |||
| 0.054 | 0.027 | 0.054 | Adenosine deaminase inhibitor | |||
| 0.05 | 0.023 | 0.05 | Glutamate (mGluR group III) agonist | |||
| 0.036 | 0.009 | 0.036 | Purinergic P2Y15 antagonist | 0.031 0.015 CID_80579 | ||
| 0.093 | 0.067 | 0.093 | Xanthine oxidase inhibitor | |||
| 0.048 | 0.022 | 0.048 | Kainate receptor antagonist | |||
| 0.082 | 0.056 | 0.082 | Caspase 7 inhibitor | 0.075 0.073 CID_80579 | ||
| 0.039 | 0.013 | 0.039 | Lysophosphatidic acid 2 receptor antagonist | 0.037 0.014 CID_80579 | ||
| 0.03 | 0.005 | 0.03 | Alpha 2a adrenoreceptor agonist | |||
| 0.065 | 0.039 | 0.065 | Trypsin inhibitor | |||
| 0.037 | 0.012 | 0.037 | Nicotinic alpha3beta4 receptor agonist | 0.027 0.025 CID_80579 | ||
| 0.09 | 0.065 | 0.09 | Fibroblast growth factor 1 antagonist | |||
| 0.117 | 0.093 | 0.117 | Ribosomal protein S6 kinase inhibitor | |||
| 0.068 | 0.044 | 0.068 | MDM2 inhibitor | |||
| 0.088 | 0.063 | 0.121 | Potassium channel activator | 0.121 0.032 CID_80579 | CID_80579 | |
| 0.048 | 0.023 | 0.048 | Guanylate cyclase inhibitor | |||
| 0.09 | 0.066 | 0.09 | MAO B inhibitor | |||
| 0.062 | 0.038 | 0.062 | Adenosine A1 receptor antagonist | |||
| 0.066 | 0.042 | 0.077 | Protease 3C (Human rhinovirus) inhibitor | 0.077 0.03 CID_80579 | CID_80579 | |
| 0.047 | 0.024 | 0.047 | Histamine H1 receptor agonist | |||
| 0.097 | 0.074 | 0.118 | Mediator release inhibitor | 0.118 0.049 CID_80579 | CID_80579 | |
| 0.057 | 0.034 | 0.057 | NMDA 2B receptor antagonist | |||
| 0.084 | 0.061 | 0.084 | Transcription factor NF kappa B stimulant | 0.081 0.068 CID_80579 | ||
| 0.045 | 0.022 | 0.045 | Histone deacetylase class I inhibitor | 0.042 0.025 CID_80579 | ||
| 0.033 | 0.01 | 0.033 | Integrin alpha2beta1 antagonist | |||
| 0.094 | 0.071 | 0.094 | Alpha 2c adrenoreceptor antagonist | |||
| 0.073 | 0.05 | 0.078 | Telomerase inhibitor | 0.078 0.046 CID_80579 | CID_80579 | |
| 0.059 | 0.037 | 0.059 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.088 | 0.066 | 0.088 | Polo-like kinase-1 inhibitor | 0.082 0.078 CID_80579 | ||
| 0.027 | 0.005 | 0.027 | Alpha 2c adrenoreceptor agonist | 0.019 0.012 CID_80579 | ||
| 0.043 | 0.021 | 0.043 | 5 Hydroxytryptamine 2B agonist | |||
| 0.097 | 0.075 | 0.097 | Beta glucuronidase inhibitor | 0.096 0.076 CID_80579 | ||
| 0.066 | 0.044 | 0.066 | Neutrophil collagenase inhibitor | 0.065 0.045 CID_80579 | ||
| 0.029 | 0.008 | 0.029 | ICAM 1 antagonist | 0.023 0.016 CID_80579 | ||
| 0.071 | 0.051 | 0.071 | Phospholipase D inhibitor | |||
| 0.041 | 0.021 | 0.044 | Potassium channel Kv1.1 blocker | 0.044 0.018 CID_80579 | CID_80579 | |
| 0.028 | 0.007 | 0.028 | Isoleucine-tRNA ligase inhibitor | 0.021 0.019 CID_80579 | ||
| 0.043 | 0.022 | 0.043 | AMPA 4 receptor antagonist | |||
| 0.055 | 0.035 | 0.055 | Alpha tubulin antagonist | |||
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | |||
| 0.091 | 0.071 | 0.101 | Interleukin 12 antagonist | 0.101 0.052 CID_80579 | CID_80579 | |
| 0.057 | 0.037 | 0.064 | Leukotriene C antagonist | 0.064 0.022 CID_80579 | CID_80579 | |
| 0.044 | 0.024 | 0.044 | Thymidine kinase inhibitor | |||
| 0.063 | 0.043 | 0.063 | Phosphodiesterase VII inhibitor | |||
| 0.054 | 0.035 | 0.054 | Histamine agonist | |||
| 0.052 | 0.033 | 0.055 | Beta 2 adrenoreceptor antagonist | 0.055 0.03 CID_80579 | CID_80579 | |
| 0.047 | 0.029 | 0.066 | Purinergic P2X4 antagonist | 0.066 0.011 CID_80579 | CID_80579 | |
| 0.111 | 0.093 | 0.111 | Protein-tyrosine kinase Lyn inhibitor | |||
| 0.054 | 0.036 | 0.054 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.074 | 0.056 | 0.074 | Na+ K+ transporting ATPase inhibitor | |||
| 0.026 | 0.009 | 0.026 | Imidazoline I1 receptor antagonist | 0.022 0.013 CID_80579 | ||
| 0.036 | 0.019 | 0.036 | Glutamate (mGluR4) agonist | |||
| 0.038 | 0.021 | 0.038 | Retinoid X alpha receptor agonist | |||
| 0.055 | 0.039 | 0.056 | Carbonic anhydrase II inhibitor | 0.056 0.038 CID_80579 | CID_80579 | |
| 0.071 | 0.054 | 0.09 | Metalloproteinase-9 inhibitor | 0.09 0.037 CID_80579 | CID_80579 | |
| 0.058 | 0.042 | 0.058 | Raf kinase B inhibitor | 0.053 0.047 CID_80579 | ||
| 0.061 | 0.045 | 0.061 | Carbonic anhydrase inhibitor | 0.061 0.045 CID_80579 | ||
| 0.036 | 0.02 | 0.036 | Adenosine uptake inhibitor | |||
| 0.032 | 0.016 | 0.032 | CDK4/cyclin D3 inhibitor | |||
| 0.053 | 0.038 | 0.053 | Leukotriene B4 antagonist | |||
| 0.044 | 0.028 | 0.044 | GABA B receptor antagonist | |||
| 0.023 | 0.007 | 0.023 | Estrogen-related receptor gamma agonist | 0.019 0.011 CID_80579 | ||
| 0.04 | 0.025 | 0.04 | Factor VIIa inhibitor | |||
| 0.049 | 0.033 | 0.049 | Histamine H4 receptor antagonist | |||
| 0.057 | 0.041 | 0.057 | Dopamine uptake inhibitor | |||
| 0.021 | 0.006 | 0.021 | Purinergic P2Y1 agonist | |||
| 0.045 | 0.03 | 0.045 | Beta adrenoreceptor agonist | 0.045 0.031 CID_80579 | ||
| 0.048 | 0.033 | 0.048 | AMPA receptor antagonist | |||
| 0.054 | 0.04 | 0.058 | Carbonic anhydrase I inhibitor | 0.058 0.037 CID_80579 | CID_80579 | |
| 0.028 | 0.014 | 0.039 | NMDA receptor glycine site antagonist | 0.039 0.008 CID_80579 | CID_80579 | |
| 0.069 | 0.055 | 0.069 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.051 | 0.036 | 0.051 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.059 | 0.044 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.04 | 0.026 | 0.04 | Vascular adhesion protein 1 inhibitor | |||
| 0.06 | 0.046 | 0.06 | 5 Hydroxytryptamine 2A agonist | |||
| 0.036 | 0.022 | 0.043 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.043 0.013 CID_80579 | CID_80579 | |
| 0.145 | 0.131 | 0.145 | Death-associated protein kinase 3 inhibitor | |||
| 0.025 | 0.012 | 0.025 | Glutamate (mGluR1a) agonist | |||
| 0.04 | 0.027 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.079 | 0.065 | 0.079 | Thioredoxin reductase inhibitor | |||
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.022 | 0.008 | 0.022 | Antibiotic Anthracycline-like | |||
| 0.039 | 0.026 | 0.039 | Glutamate (mGluR group II) antagonist | |||
| 0.028 | 0.015 | 0.028 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.024 CID_80579 | ||
| 0.029 | 0.016 | 0.029 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.117 | 0.104 | 0.173 | Cytidine deaminase inhibitor | 0.173 0.06 CID_80579 | CID_80579 | |
| 0.049 | 0.036 | 0.049 | Squalene epoxidase inhibitor | |||
| 0.063 | 0.05 | 0.069 | Beta adrenoreceptor antagonist | 0.069 0.039 CID_80579 | CID_80579 | |
| 0.219 | 0.207 | 0.326 | Alpha-glucosidase inhibitor | 0.326 0.147 CID_80579 | CID_80579 | |
| 0.048 | 0.035 | 0.048 | Plasminogen activator inhibitor antagonist | |||
| 0.028 | 0.015 | 0.051 | Thyroid hormone agonist | 0.051 0.004 CID_80579 | CID_80579 | |
| 0.059 | 0.047 | 0.059 | 5 Hydroxytryptamine 5A antagonist | |||
| 0.071 | 0.059 | 0.1 | ErbB-4 antagonist | 0.1 0.04 CID_80579 | CID_80579 | |
| 0.03 | 0.019 | 0.03 | Liver X receptor beta antagonist | |||
| 0.06 | 0.048 | 0.06 | Adenosine A2 receptor antagonist | |||
| 0.042 | 0.031 | 0.048 | Carbonic anhydrase IV inhibitor | 0.048 0.026 CID_80579 | CID_80579 | |
| 0.042 | 0.031 | 0.042 | Leukocyte elastase inhibitor | 0.04 0.033 CID_80579 | ||
| 0.034 | 0.023 | 0.043 | Melatonin receptor 1A agonist | 0.043 0.011 CID_80579 | CID_80579 | |
| 0.022 | 0.011 | 0.022 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.02 0.016 CID_80579 | ||
| 0.057 | 0.046 | 0.057 | Phosphodiesterase 1B inhibitor | |||
| 0.019 | 0.008 | 0.019 | NMDA receptor phencyclidine site antagonist | |||
| 0.041 | 0.031 | 0.041 | Oxytocin agonist | |||
| 0.031 | 0.021 | 0.059 | Epoxide hydrolase 1 inhibitor | 0.059 0.004 CID_80579 | CID_80579 | |
| 0.028 | 0.018 | 0.028 | Lysine carboxypeptidase inhibitor | |||
| 0.026 | 0.016 | 0.026 | Acid ceramidase inhibitor | |||
| 0.141 | 0.131 | 0.141 | Antimitotic | |||
| 0.194 | 0.185 | 0.211 | Antithrombotic | 0.211 0.164 CID_80579 | CID_80579 | |
| 0.185 | 0.176 | 0.185 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.052 | 0.043 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | 0.053 0.041 CID_80579 | CID_80579 | |
| 0.078 | 0.068 | 0.078 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.077 0.07 CID_80579 | ||
| 0.048 | 0.039 | 0.048 | Carbonic anhydrase XII inhibitor | |||
| 0.026 | 0.017 | 0.026 | Complement factor 1r inhibitor | |||
| 0.022 | 0.013 | 0.022 | Glutaminyl-peptide cyclotransferase inhibitor | |||
| 0.061 | 0.052 | 0.061 | Aryl hydrocarbon receptor antagonist | |||
| 0.028 | 0.018 | 0.028 | Hedgehog signaling activator | |||
| 0.099 | 0.09 | 0.112 | TRPA1 agonist | 0.112 0.068 CID_80579 | CID_80579 | |
| 0.055 | 0.046 | 0.055 | Carbonic anhydrase stimulant | |||
| 0.033 | 0.024 | 0.033 | Purinergic P2Y2 antagonist | |||
| 0.033 | 0.024 | 0.033 | Protein kinase (CK2) beta inhibitor | |||
| 0.053 | 0.045 | 0.053 | MAP kinase kinase 9 inhibitor | |||
| 0.043 | 0.036 | 0.054 | Carbonic anhydrase VII inhibitor | 0.054 0.024 CID_80579 | CID_80579 | |
| 0.098 | 0.09 | 0.098 | Cholesterol synthesis inhibitor | |||
| 0.055 | 0.048 | 0.057 | Androgen agonist | 0.057 0.045 CID_80579 | CID_80579 | |
| 0.092 | 0.085 | 0.126 | Protein kinase (CK2) alpha inhibitor | 0.126 0.058 CID_80579 | CID_80579 | |
| 0.013 | 0.005 | 0.013 | Imidazoline I2 receptor antagonist | 0.013 0.006 CID_80579 | ||
| 0.024 | 0.017 | 0.024 | Histone deacetylase 1 inhibitor | |||
| 0.017 | 0.01 | 0.017 | CDK2/cyclin A3 inhibitor | |||
| 0.072 | 0.065 | 0.095 | Sphingosine 1-phosphate receptor antagonist | 0.095 0.025 CID_80579 | CID_80579 | |
| 0.06 | 0.053 | 0.06 | Prolactin release inhibitor | |||
| 0.071 | 0.065 | 0.071 | Estrogen receptor alpha antagonist | |||
| 0.034 | 0.028 | 0.04 | Inosine monophosphate dehydrogenase inhibitor | 0.04 0.021 CID_80579 | CID_80579 | |
| 0.032 | 0.025 | 0.032 | Histone deacetylase 2 inhibitor | |||
| 0.034 | 0.028 | 0.048 | Delayed rectifier potassium channel activator | 0.048 0.017 CID_80579 | CID_80579 | |
| 0.034 | 0.028 | 0.048 | Potassium channel KCNQ activator | 0.048 0.017 CID_80579 | CID_80579 | |
| 0.039 | 0.033 | 0.044 | Sphingosine kinase 1 inhibitor | 0.044 0.024 CID_80579 | CID_80579 | |
| 0.031 | 0.026 | 0.031 | Liver X receptor beta agonist | |||
| 0.024 | 0.019 | 0.024 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.028 | 0.023 | 0.028 | Glutamate (mGluR2) antagonist | |||
| 0.104 | 0.099 | 0.104 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.037 | 0.031 | 0.048 | Histone deacetylase 9 inhibitor | 0.048 0.017 CID_80579 | CID_80579 | |
| 0.067 | 0.061 | 0.067 | Rho-associated kinase I inhibitor | |||
| 0.015 | 0.011 | 0.015 | Thyroid hormone alpha antagonist | |||
| 0.077 | 0.072 | 0.077 | Insulin growth factor antagonist | |||
| 0.018 | 0.013 | 0.018 | Methylmalonyl-CoA mutase inhibitor | |||
| 0.042 | 0.037 | 0.048 | Glycine transporter 2 inhibitor | 0.048 0.032 CID_80579 | CID_80579 | |
| 0.031 | 0.027 | 0.031 | ATR kinase inhibitor | |||
| 0.02 | 0.016 | 0.031 | Neuraminidase (Influenza B) inhibitor | 0.031 0.004 CID_80579 | CID_80579 | |
| 0.05 | 0.046 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.059 0.037 CID_80579 | CID_80579 | |
| 0.022 | 0.017 | 0.022 | Beta 1 adrenoreceptor agonist | 0.022 0.017 CID_80579 | ||
| 0.038 | 0.033 | 0.038 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.087 | 0.083 | 0.087 | Insulin receptor antagonist | |||
| 0.096 | 0.092 | 0.096 | c-Src kinase inhibitor | |||
| 0.013 | 0.009 | 0.018 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.018 0.005 CID_80579 | CID_80579 | |
| 0.033 | 0.029 | 0.033 | Ceramide glucosyltransferase inhibitor | |||
| 0.065 | 0.061 | 0.108 | Epoxide hydrolase inhibitor | 0.108 0.021 CID_80579 | CID_80579 | |
| 0.053 | 0.05 | 0.053 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.052 | 0.048 | 0.052 | Alpha 1 adrenoreceptor agonist | |||
| 0.012 | 0.009 | 0.012 | Glutamate (mGluR6) agonist | |||
| 0.016 | 0.013 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.069 | 0.067 | 0.09 | Metalloproteinase-2 inhibitor | 0.09 0.044 CID_80579 | CID_80579 | |
| 0.037 | 0.034 | 0.042 | Leukotriene C4 antagonist | 0.042 0.02 CID_80579 | CID_80579 | |
| 0.027 | 0.024 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.053 | 0.051 | 0.059 | Collagenase 3 inhibitor | 0.059 0.042 CID_80579 | CID_80579 | |
| 0.024 | 0.022 | 0.024 | Vanilloid 2 agonist | |||
| 0.007 | 0.006 | 0.007 | DNA topoisomerase III inhibitor | |||
| 0.017 | 0.016 | 0.017 | Complement factor D inhibitor | |||
| 0.025 | 0.024 | 0.037 | Cyclin E2 inhibitor | 0.037 0.014 CID_80579 | CID_80579 | |
| 0.133 | 0.132 | 0.287 | Interleukin antagonist | 0.287 0.051 CID_80579 | CID_80579 | |
| 0.032 | 0.033 | 0.039 | Factor XIIIa inhibitor | 0.039 0.024 CID_80579 | CID_80579 | |
| 0.015 | 0.016 | 0.019 | Nicotinic acid receptor 1 antagonist | 0.019 0.01 CID_80579 | CID_80579 | |
| 0.017 | 0.018 | 0.023 | Hexokinase stimulant | 0.023 0.012 CID_80579 | CID_80579 | |
| 0.031 | 0.033 | 0.053 | Histone deacetylase 7 inhibitor | 0.053 0.017 CID_80579 | CID_80579 | |
| 0.072 | 0.076 | 0.101 | Glutathione S-transferase inhibitor | 0.101 0.037 CID_80579 | CID_80579 | |
| 0.027 | 0.03 | 0.035 | Cholesterol ester transfer protein antagonist | 0.035 0.018 CID_80579 | CID_80579 | |
| 0.068 | 0.071 | 0.072 | Potassium channel (Tandem pore domain) blocker | 0.072 0.056 CID_80579 | CID_80579 | |
| 0.056 | 0.059 | 0.065 | Matrix metalloproteinase inhibitor | 0.065 0.048 CID_80579 | CID_80579 | |
| 0.013 | 0.017 | 0.024 | Carbonic anhydrase X inhibitor | 0.024 0.006 CID_80579 | CID_80579 | |
| 0.013 | 0.017 | 0.024 | Carbonic anhydrase VIII inhibitor | 0.024 0.006 CID_80579 | CID_80579 | |
| 0.093 | 0.097 | 0.122 | Proteasome inhibitor | 0.122 0.063 CID_80579 | CID_80579 | |
| 0.038 | 0.043 | 0.071 | Dihydroorotase inhibitor | 0.071 0.011 CID_80579 | CID_80579 | |
| 0.009 | 0.016 | 0.02 | Carbonic anhydrase XI inhibitor | 0.02 0.004 CID_80579 | CID_80579 | |
| 0.026 | 0.034 | 0.035 | Methionyl aminopeptidase 1 inhibitor | 0.035 0.017 CID_80579 | CID_80579 | |
| 0.006 | 0.013 | 0.012 | Thyroid hormone beta agonist | 0.012 0.004 CID_80579 | CID_80579 | |
| 0.04 | 0.048 | 0.048 | Adenosine A2b receptor antagonist | 0.048 0.036 CID_80579 | CID_80579 | |
| 0.031 | 0.041 | 0.046 | Histone deacetylase 8 inhibitor | 0.046 0.025 CID_80579 | CID_80579 | |
| 0.077 | 0.087 | 0.089 | Protein kinase (CK2) inhibitor | 0.089 0.073 CID_80579 | CID_80579 | |
| 0.05 | 0.06 | 0.092 | Selectin antagonist | 0.092 0.031 CID_80579 | CID_80579 | |
| 0.032 | 0.044 | 0.036 | MAP3K5 inhibitor | 0.036 0.032 CID_80579 | CID_80579 | |
| 0.021 | 0.034 | 0.025 | Nicotinic acid receptor 2 antagonist | 0.025 0.021 CID_80579 | CID_80579 | |
| 0.008 | 0.024 | 0.014 | Human herpes virus 5 capsid protein P40 inhibitor | 0.014 0.008 CID_80579 | CID_80579 | |
| 0.143 | 0.159 | 0.197 | Growth factor agonist | 0.197 0.065 CID_80579 | CID_80579 | |
| 0.038 | 0.056 | 0.072 | Dihydroorotate dehydrogenase inhibitor | 0.072 0.021 CID_80579 | CID_80579 | |
| 0.024 | 0.045 | 0.035 | Nicotinic acid receptor agonist | 0.035 0.027 CID_80579 | CID_80579 | |
| 0.025 | 0.046 | 0.037 | Carnitine palmitoyltransferase 1 inhibitor | 0.037 0.019 CID_80579 | CID_80579 | |
| 0.023 | 0.043 | 0.026 | Glucosylceramidase stimulant | 0.026 0.024 CID_80579 | CID_80579 | |
| 0.024 | 0.048 | 0.037 | Carnitine palmitoyltransferase inhibitor | 0.037 0.02 CID_80579 | CID_80579 | |
| 0.129 | 0.153 | 0.182 | EphB2 antagonist | 0.182 0.101 CID_80579 | CID_80579 | |
| 0.046 | 0.071 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.035 CID_80579 | CID_80579 | |
| 0.024 | 0.05 | 0.03 | Calcium release-activated channel blocker | 0.03 0.029 CID_80579 | CID_80579 | |
| 0.008 | 0.034 | 0.031 | Melatonin receptor 1A antagonist | 0.031 0.004 CID_80579 | CID_80579 | |
| 0.092 | 0.118 | 0.194 | M17 leucyl aminopeptidase inhibitor | 0.194 0.035 CID_80579 | CID_80579 | |
| 0.015 | 0.041 | 0.027 | Protease (Human cytomegalovirus) inhibitor | 0.027 0.01 CID_80579 | CID_80579 | |
| 0.007 | 0.035 | 0.011 | Melatonin 2 antagonist | 0.011 0.01 CID_80579 | CID_80579 | |
| 0.027 | 0.056 | 0.039 | CDK5/p25 inhibitor | 0.039 0.031 CID_80579 | CID_80579 | |
| 0.063 | 0.092 | 0.075 | ErbB-3 antagonist | 0.075 0.068 CID_80579 | CID_80579 | |
| 0.199 | 0.229 | 0.32 | Transcription factor inhibitor | 0.32 0.144 CID_80579 | CID_80579 | |
| 0.03 | 0.061 | 0.045 | Matrix metalloproteinase 1 inhibitor | 0.045 0.042 CID_80579 | CID_80579 | |
| 0.013 | 0.049 | 0.019 | Caspase 8 inhibitor | 0.019 0.015 CID_80579 | CID_80579 | |
| 0.063 | 0.102 | 0.086 | Neuropeptide Y antagonist | 0.086 0.051 CID_80579 | CID_80579 | |
| 0.093 | 0.133 | 0.162 | Interleukin 4 antagonist | 0.162 0.04 CID_80579 | CID_80579 | |
| 0.036 | 0.077 | 0.046 | HCV NS3/NS4A protease inhibitor | 0.046 0.04 CID_80579 | CID_80579 | |
| 0.19 | 0.232 | 0.345 | DNA polymerase beta inhibitor | 0.345 0.141 CID_80579 | CID_80579 | |
| 0.083 | 0.125 | 0.138 | Caspase 3 inhibitor | 0.138 0.038 CID_80579 | CID_80579 | |
| 0.092 | 0.135 | 0.168 | Histone deacetylase SIRT1 inhibitor | 0.168 0.047 CID_80579 | CID_80579 | |
| 0.187 | 0.238 | 0.307 | DNA directed DNA polymerase inhibitor | 0.307 0.158 CID_80579 | CID_80579 | |
| 0.045 | 0.103 | 0.104 | Histone deacetylase SIRT2 inhibitor | 0.104 0.026 CID_80579 | CID_80579 | |
| 0.091 | 0.149 | 0.12 | Antibacterial (Helicobacter pylori) | 0.12 0.082 CID_80579 | CID_80579 | |
| 0.024 | 0.088 | 0.057 | Acetyl-CoA carboxylase inhibitor | 0.057 0.016 CID_80579 | CID_80579 | |
| 0.04 | 0.118 | 0.188 | Neuraminidase (influenza) inhibitor | 0.188 0.005 CID_80579 | CID_80579 | |
| 0.067 | 0.146 | 0.147 | Histone deacetylase class III inhibitor | 0.147 0.047 CID_80579 | CID_80579 | |
| 0.035 | 0.116 | 0.069 | Prostaglandin-E synthase inhibitor | 0.069 0.05 CID_80579 | CID_80579 | |
| 0.075 | 0.156 | 0.105 | CDC-like kinase 3 inhibitor | 0.105 0.069 CID_80579 | CID_80579 | |
| 0.075 | 0.161 | 0.162 | CDK3/cyclin E inhibitor | 0.162 0.02 CID_80579 | CID_80579 | |
| 0.017 | 0.118 | 0.06 | Melanin-concentrating hormone receptor 1 antagonist | 0.06 0.03 CID_80579 | CID_80579 | |
| 0.024 | 0.13 | 0.172 | Neuraminidase inhibitor | 0.172 0.005 CID_80579 | CID_80579 | |
| 0.022 | 0.13 | 0.083 | Neuraminidase (Influenza A) inhibitor | 0.083 0.005 CID_80579 | CID_80579 | |
| 0.005 | 0.119 | 0.021 | Acetyl-CoA carboxylase 2 inhibitor | 0.021 0.017 CID_80579 | CID_80579 | |
| 0.127 | 0.276 | 0.256 | Peptidyltransferase inhibitor | 0.256 0.046 CID_80579 | CID_80579 | |
| 0.023 | 0.18 | 0.07 | Vanilloid antagonist | 0.07 0.056 CID_80579 | CID_80579 | |
| 0.011 | 0.169 | 0.04 | Melatonin 2 agonist | 0.04 0.016 CID_80579 | CID_80579 | |
| 0.013 | 0.18 | 0.039 | Melatonin 1 agonist | 0.039 0.016 CID_80579 | CID_80579 | |
| 0.01 | 0.213 | 0.04 | Melatonin agonist | 0.04 0.015 CID_80579 | CID_80579 | |
| 0.065 | 0.269 | 0.134 | Aurora-C kinase inhibitor | 0.134 0.075 CID_80579 | CID_80579 | |
| 0.089 | 0.302 | 0.251 | Beta lactamase inhibitor | 0.251 0.156 CID_80579 | CID_80579 | |
| 0.005 | 0.224 | 0.035 | Melatonin 1 antagonist | 0.035 0.006 CID_80579 | CID_80579 | |
| 0.005 | 0.257 | 0.054 | Melatonin antagonist | 0.054 0.007 CID_80579 | CID_80579 | |
| 0.027 | 0.283 | 0.052 | DNA helicase inhibitor | 0.052 0.043 CID_80579 | CID_80579 | |
| 0.084 | 0.358 | 0.24 | Death-associated protein kinase 2 inhibitor | 0.24 0.015 CID_80579 | CID_80579 | |
| 0.064 | 0.379 | 0.198 | Thioredoxin glutathione reductase inhibitor | 0.198 0.175 CID_80579 | CID_80579 | |
| 0.068 | 0.558 | 0.171 | Cyclin-dependent kinase 3 inhibitor | 0.171 0.059 CID_80579 | CID_80579 | |
| 0.006 | 0.509 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.019 0.011 CID_80579 | CID_80579 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |